AFT outlicenses Maxigesic in South America

21 June 2019 - Deborah Wilkes


New Zealand's AFT Pharmaceuticals has announced its first outlicensing deal for the Maxigesic combination painkiller in South America.

Click tags below for more information on topics:


Annual Subscription Holder?

Sign in to continue reading.

Sign In

Back to Industry News

Share this page: